Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Stock Plummets 24 Percent on Lackluster Q2 Report

NEW YORK (GenomeWeb News) - Shares in Molecular Devices were down 24 percent, or $6.88, to $22.16 in mid-afternoon trading today after the company reported lackluster results for its second quarter.

As GenomeWeb News reported today, Molecular Devices reported a net loss of $460,000 for the quarter, compared to a profit year over year of $3.7 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.